PURE Bioscience, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations
PURE Bioscience, Inc. (PURE) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations of 113.52 thousand shares for the 12-month period ending 2018-07-31, per its 10-K filed 2018-10-25.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations · last filed 2018-10-25
- PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, expirations for fiscal 2018 was 113.52K shares, a 12.25% decline from fiscal 2017.
- PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, expirations for fiscal 2017 was 129.37K shares.
- PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, expirations for fiscal 2016 was -15.46M shares.
- PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, expirations for fiscal 2015 was -52.84K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations 12 month as first filed |
|---|---|---|
| 2018-07-31 | 113.52K shares 10-K · filed 2018-10-25 | |
| 2017-07-31 | 129.37K shares 10-K · filed 2018-10-25 | -129.37K shares 10-K · filed 2017-10-26 |
| 2016-07-31 | -15.46M shares 10-K · filed 2017-10-26 | |
| 2015-07-31 | -52.84K shares 10-K · filed 2016-10-27 |